Biotin anti-mouse CD45 [30-F11] and 5 more items

The University of Virginia has awarded contract A207_PO-0460191-V2 to BioLegend Inc., effective July 27, 2026, with a cumulative contract value of $1,297.00. The contract encompasses the procurement of specialized research reagents and antibodies for delivery to Min Xiang at the University of Virginia in Virginia. The awarded products consist of six distinct line items including fluorescently-labeled monoclonal antibodies and related research reagents designed for flow cytometry applications, specifically targeting mouse immune cell markers.

The contract deliverables include biotin-conjugated anti-mouse CD45 and anti-mouse CD185 (CXCR5) antibodies, Brefeldin A Solution (1,000X), and multiple fluorescently-conjugated antibodies targeting immune checkpoint and activation markers including PE/Cyanine7 anti-mouse FR4, PerCP/Cyanine5.5 anti-mouse CD357 (GITR), and Brilliant Violet 711 anti-mouse CD279 (PD-1). These reagents are typical of those used in immunological research and laboratory diagnostics within academic research settings. The contract represents a material purchase order for specialized scientific supplies to support the University of Virginia's research operations.